CN1194736C - 治疗乙肝的组合物 - Google Patents
治疗乙肝的组合物 Download PDFInfo
- Publication number
- CN1194736C CN1194736C CN 02146556 CN02146556A CN1194736C CN 1194736 C CN1194736 C CN 1194736C CN 02146556 CN02146556 CN 02146556 CN 02146556 A CN02146556 A CN 02146556A CN 1194736 C CN1194736 C CN 1194736C
- Authority
- CN
- China
- Prior art keywords
- solution
- compositions
- amount
- ethanol
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 18
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 239000000243 solution Substances 0.000 claims description 30
- 238000012360 testing method Methods 0.000 claims description 30
- 239000000284 extract Substances 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000002481 ethanol extraction Methods 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 16
- 239000002775 capsule Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 238000003809 water extraction Methods 0.000 claims description 9
- 238000001704 evaporation Methods 0.000 claims description 8
- 230000008020 evaporation Effects 0.000 claims description 8
- 239000013558 reference substance Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 238000004809 thin layer chromatography Methods 0.000 claims description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 6
- 239000006286 aqueous extract Substances 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- 239000012086 standard solution Substances 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- 241000222336 Ganoderma Species 0.000 claims description 4
- 244000061458 Solanum melongena Species 0.000 claims description 4
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 230000000274 adsorptive effect Effects 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 3
- 229960001763 zinc sulfate Drugs 0.000 claims description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 3
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- 241001071917 Lithospermum Species 0.000 claims description 2
- 241000222640 Polyporus Species 0.000 claims description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 2
- 229930183118 Tanshinone Natural products 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- ZRBROGSAUIUIJE-UHFFFAOYSA-N azanium;azane;chloride Chemical compound N.[NH4+].[Cl-] ZRBROGSAUIUIJE-UHFFFAOYSA-N 0.000 claims description 2
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 claims description 2
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- 239000011651 chromium Substances 0.000 claims description 2
- RSJOBNMOMQFPKQ-ZVGUSBNCSA-L copper;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Cu+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O RSJOBNMOMQFPKQ-ZVGUSBNCSA-L 0.000 claims description 2
- 230000003760 hair shine Effects 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000011550 stock solution Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 239000012085 test solution Substances 0.000 claims description 2
- 238000004448 titration Methods 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims 3
- 239000000470 constituent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 238000011160 research Methods 0.000 abstract description 4
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 2
- 241000118825 Alkanna tinctoria Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000222355 Trametes versicolor Species 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 238000011084 recovery Methods 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 206010008909 Chronic Hepatitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 101710142246 External core antigen Proteins 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 206010019759 Hepatitis chronic persistent Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241001130943 Phyllanthus <Aves> Species 0.000 description 2
- 241000222341 Polyporaceae Species 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- -1 1 hour Substances 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000272522 Anas Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000173207 Phyllanthus amarus Species 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000906946 Sphingomonas carri Species 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
试验次数 1 2 3 4 5 6 |
糅质含量(%) 11.2 11.1 11.2 11.3 11.2 11.4 |
平均值(%) 11.2 |
RSD(%) 0.9 |
原始量(mg)加入量(mg)测得量(mg)回收率(X%)平均回收率(X%) RSD(%) |
59.9 40.1 98.3 95.860.0 40.1 98.5 96.059.9 40.1 97.7 94.3 96.2 1.5559.7 40.1 99.1 98.460.0 40.1 98.7 96.5 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02146556 CN1194736C (zh) | 2002-10-22 | 2002-10-22 | 治疗乙肝的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02146556 CN1194736C (zh) | 2002-10-22 | 2002-10-22 | 治疗乙肝的组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1491684A CN1491684A (zh) | 2004-04-28 |
CN1194736C true CN1194736C (zh) | 2005-03-30 |
Family
ID=34232780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02146556 Expired - Lifetime CN1194736C (zh) | 2002-10-22 | 2002-10-22 | 治疗乙肝的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1194736C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108452008A (zh) * | 2017-02-22 | 2018-08-28 | 北京汉典制药有限公司 | 一种包含叶下珠、云芝、丹参和紫草的中药组合物在制备抑制肝癌术后复发的药物中的应用 |
CN108452009A (zh) * | 2017-02-22 | 2018-08-28 | 北京汉典制药有限公司 | 一种包含叶下珠、云芝、丹参和紫草的中药组合物在制备治疗肝癌的药物中的应用 |
CN107308120A (zh) * | 2017-08-06 | 2017-11-03 | 周海云 | 一种中药颗粒的制备工艺 |
CN108079055B (zh) * | 2017-12-19 | 2021-04-20 | 北京汉典制药有限公司 | 一种中药组合物和索拉菲尼的组合及其在制备用于治疗肝癌的药物中的应用 |
WO2020010519A1 (zh) * | 2018-07-10 | 2020-01-16 | 北京汉典制药有限公司 | 一种治疗肝癌和抑制肝癌术后复发的中药组合物 |
CN111060646B (zh) * | 2020-01-18 | 2021-08-31 | 河北中医学院 | 一种叶下珠药材、颗粒及标煎液干粉的快速多信息薄层鉴别方法 |
-
2002
- 2002-10-22 CN CN 02146556 patent/CN1194736C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1491684A (zh) | 2004-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106924406B (zh) | 一种用于治疗艾滋病的辅助用药的药物组合物及其制备方法 | |
CN1958005A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN101862346B (zh) | 人参酸性多糖在制备降血糖药物中的应用 | |
CN1194736C (zh) | 治疗乙肝的组合物 | |
CN1957999B (zh) | 一种中药组合物及其制备方法和检测方法 | |
CN1883673A (zh) | 一种复方太子参制剂及其生产方法 | |
CN1887324A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN101623437B (zh) | 注射用生脉制剂及其制备方法 | |
CN101167781A (zh) | 口服降血糖红薯叶单方中药及其制备方法 | |
CN101293008A (zh) | 一种治疗慢性支气管炎的药物组合物及其制备方法 | |
CN1927324A (zh) | 用于治疗妇女月经不调中药制剂的制备方法 | |
CN101879271B (zh) | 橘红胶囊的质量检测方法 | |
CN1872280A (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN104784192B (zh) | 蚌肉寡糖在制备降血糖药物中的应用及其制备方法 | |
CN1434042A (zh) | 蒲黄提取物及其制备方法和用途 | |
CN108159297B (zh) | 一种疏风解毒胶囊及其制备方法与制药用途 | |
CN1294948C (zh) | 一种益气健脾滋补肝肾的药物及其制备方法 | |
CN1943718A (zh) | 一种中药组合物及其制备方法 | |
CN101249129B (zh) | 一种治疗糖尿病的中药提取物组合物及其医药用途 | |
CN1923268B (zh) | 一种用于治疗鼻炎的药物组合物及其制备方法和质量控制方法 | |
CN1311864C (zh) | 贞芪扶正输液剂 | |
CN1237998C (zh) | 治疗小儿咳喘的泡腾片 | |
CN1891283A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN100355424C (zh) | 治疗糖尿病的楤木提取物及楤木皂苷在制备治疗糖尿病的药物中的应用 | |
CN1181836C (zh) | 一种治疗糖尿病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: BEIJING RED SUN PHARMACEUTICAL Co.,Ltd. Assignor: Beijing Handian Chinese and Western Medicine Research Development Center Contract fulfillment period: 2005.5.16 to 2013.5.16 Contract record no.: 2009990000343 Denomination of invention: Composition for treating hepatitis B Granted publication date: 20050330 License type: Exclusive license Record date: 20090421 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2005.5.16 TO 2013.5.16; CHANGE OF CONTRACT Name of requester: BEIJING RED SUN PHARMACEUTICAL CO., LTD. Effective date: 20090421 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151127 Address after: 105500 No. 232 water source road, Miyun Economic Development Zone, Beijing, China Patentee after: Beijing Handian Pharmaceutical Co.,Ltd. Address before: 100700 Beijing city Dongzhimen north warehouse No. 18 China in Beijing Handian Chinese Academy of traditional Chinese medicine and Western Medicine Research Development Center Patentee before: Beijing Handian Chinese and Western Medicine Research Development Center |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 105500 No. 232 water source road, Miyun Economic Development Zone, Beijing, China Patentee after: Beijing Handian Pharmaceutical Co.,Ltd. Address before: 105500 No. 232 water source road, Miyun Economic Development Zone, Beijing, China Patentee before: Beijing Handian Pharmaceutical Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20050330 |